A detailed history of Guggenheim Capital LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Guggenheim Capital LLC holds 59,268 shares of BDX stock, worth $13.5 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
59,268
Previous 59,000 0.45%
Holding current value
$13.5 Million
Previous $13.8 Million 3.63%
% of portfolio
0.1%
Previous 0.1%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$221.47 - $242.41 $59,353 - $64,965
268 Added 0.45%
59,268 $14.3 Million
Q2 2024

Aug 14, 2024

BUY
$225.07 - $246.17 $2.17 Million - $2.37 Million
9,644 Added 19.54%
59,000 $13.8 Million
Q1 2024

May 14, 2024

BUY
$233.45 - $247.73 $258,429 - $274,237
1,107 Added 2.29%
49,356 $12.2 Million
Q4 2023

Feb 14, 2024

SELL
$232.24 - $267.23 $67,814 - $78,031
-292 Reduced 0.6%
48,249 $11.8 Million
Q3 2023

Nov 14, 2023

SELL
$254.9 - $283.59 $5.86 Million - $6.52 Million
-22,978 Reduced 32.13%
48,541 $12.5 Million
Q2 2023

Aug 11, 2023

BUY
$238.39 - $265.32 $2.41 Million - $2.68 Million
10,105 Added 16.45%
71,519 $18.9 Million
Q1 2023

May 10, 2023

BUY
$229.71 - $259.35 $383,385 - $432,855
1,669 Added 2.79%
61,414 $15.2 Million
Q4 2022

Feb 14, 2023

BUY
$218.29 - $256.91 $1.11 Million - $1.31 Million
5,106 Added 9.34%
59,745 $15.2 Million
Q3 2022

Nov 14, 2022

BUY
$51.03 - $264.23 $361,751 - $1.87 Million
7,089 Added 14.91%
54,639 $12.2 Million
Q2 2022

Aug 15, 2022

SELL
$234.74 - $275.42 $57,746 - $67,753
-246 Reduced 0.51%
47,550 $11.7 Million
Q1 2022

May 16, 2022

BUY
$243.64 - $270.48 $97,212 - $107,921
399 Added 0.84%
47,796 $12.7 Million
Q4 2021

Feb 14, 2022

BUY
$230.08 - $250.94 $2.01 Million - $2.2 Million
8,751 Added 22.64%
47,397 $11.9 Million
Q3 2021

Nov 15, 2021

BUY
$232.72 - $256.47 $1.13 Million - $1.25 Million
4,858 Added 14.38%
38,646 $9.5 Million
Q2 2021

Aug 13, 2021

SELL
$232.65 - $254.58 $1.05 Million - $1.15 Million
-4,510 Reduced 11.78%
33,788 $8.22 Million
Q1 2021

May 13, 2021

BUY
$232.09 - $256.88 $1.03 Million - $1.14 Million
4,448 Added 13.14%
38,298 $9.31 Million
Q4 2020

Feb 16, 2021

SELL
$221.92 - $245.94 $281,394 - $311,851
-1,268 Reduced 3.61%
33,850 $8.47 Million
Q3 2020

Nov 13, 2020

SELL
$215.77 - $276.76 $2.65 Million - $3.4 Million
-12,292 Reduced 25.93%
35,118 $8.17 Million
Q2 2020

Aug 14, 2020

BUY
$219.9 - $263.41 $3.11 Million - $3.72 Million
14,139 Added 42.5%
47,410 $11.3 Million
Q1 2020

Jun 02, 2020

SELL
$195.69 - $279.01 $2.47 Million - $3.52 Million
-12,621 Reduced 27.5%
33,271 $7.64 Million
Q4 2019

Feb 14, 2020

BUY
$236.45 - $266.82 $1.26 Million - $1.43 Million
5,342 Added 13.17%
45,892 $12.5 Million
Q3 2019

Nov 14, 2019

SELL
$230.58 - $256.08 $1.03 Million - $1.15 Million
-4,486 Reduced 9.96%
40,550 $10.3 Million
Q2 2019

Aug 14, 2019

SELL
$217.4 - $246.08 $698,941 - $791,147
-3,215 Reduced 6.66%
45,036 $11.3 Million
Q1 2019

May 15, 2019

BUY
$206.05 - $248.17 $1.14 Million - $1.38 Million
5,546 Added 12.99%
48,251 $12 Million
Q4 2018

Feb 14, 2019

SELL
$204.73 - $257.93 $3.36 Million - $4.23 Million
-16,396 Reduced 27.74%
42,705 $9.62 Million
Q3 2018

Nov 14, 2018

BUY
$233.07 - $256.0 $641,641 - $704,768
2,753 Added 4.89%
59,101 $15.4 Million
Q2 2018

Aug 14, 2018

SELL
$208.1 - $233.85 $50.2 Million - $56.4 Million
-241,339 Reduced 81.07%
56,348 $13.5 Million
Q1 2018

May 15, 2018

SELL
$205.46 - $240.27 $24.9 Million - $29.2 Million
-121,385 Reduced 28.97%
297,687 $64.5 Million
Q4 2017

Feb 14, 2018

BUY
$189.0 - $222.64 $14.7 Million - $17.3 Million
77,914 Added 22.84%
419,072 $89.7 Million
Q3 2017

Nov 14, 2017

BUY
$186.89 - $198.9 $63.8 Million - $67.9 Million
341,158
341,158 $66.8 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.7B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.